These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Age-related macular degeneration (AMD): Alzheimer's disease in the eye? Kaarniranta K; Salminen A; Haapasalo A; Soininen H; Hiltunen M J Alzheimers Dis; 2011; 24(4):615-31. PubMed ID: 21297256 [TBL] [Abstract][Full Text] [Related]
10. The optic neuropathy of Alzheimer's disease. Sadun AA Metab Pediatr Syst Ophthalmol (1985); 1989; 12(1-3):64-8. PubMed ID: 2770524 [TBL] [Abstract][Full Text] [Related]
11. The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease. Sivak JM Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):871-80. PubMed ID: 23364356 [TBL] [Abstract][Full Text] [Related]
12. Beyond Vision: A View from Eye to Alzheimer's Disease and Dementia. Zheng C; Zeng R; Wu G; Hu Y; Yu H J Prev Alzheimers Dis; 2024; 11(2):469-483. PubMed ID: 38374754 [TBL] [Abstract][Full Text] [Related]
13. Optometric management of patients with Alzheimer's disease. Baker DR; Mendez MF; Townsend JC; Ilsen PF; Bright DC J Am Optom Assoc; 1997 Aug; 68(8):483-94. PubMed ID: 9279048 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration. Romaus-Sanjurjo D; Regueiro U; López-López M; Vázquez-Vázquez L; Ouro A; Lema I; Sobrino T Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269629 [TBL] [Abstract][Full Text] [Related]
15. Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease. Singh AK; Verma S Indian J Ophthalmol; 2020 Apr; 68(4):555-561. PubMed ID: 32174567 [TBL] [Abstract][Full Text] [Related]
16. Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression. Javaid FZ; Brenton J; Guo L; Cordeiro MF Front Neurol; 2016; 7():55. PubMed ID: 27148157 [TBL] [Abstract][Full Text] [Related]
17. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease. Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353 [TBL] [Abstract][Full Text] [Related]
18. Clinical and psychometric distinction of frontotemporal and Alzheimer dementias. Liscic RM; Storandt M; Cairns NJ; Morris JC Arch Neurol; 2007 Apr; 64(4):535-40. PubMed ID: 17420315 [TBL] [Abstract][Full Text] [Related]
19. Visual impairment in Alzheimer's disease: a critical review. Kirby E; Bandelow S; Hogervorst E J Alzheimers Dis; 2010; 21(1):15-34. PubMed ID: 20182034 [TBL] [Abstract][Full Text] [Related]
20. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]